These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies. Mori S; Fujitake J; Kuno S; Sano Y Neurosci Lett; 1988 Jul; 90(1-2):57-62. PubMed ID: 2901058 [TBL] [Abstract][Full Text] [Related]
45. The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury. Reinhard JF; Miller DB; O'Callaghan JP Neurosci Lett; 1988 Dec; 95(1-3):246-51. PubMed ID: 3265770 [TBL] [Abstract][Full Text] [Related]
46. Amine fluorescence histochemical investigation of the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian mice. Mizukawa K; Ogawa N; Sora YH Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):121-8. PubMed ID: 3258432 [TBL] [Abstract][Full Text] [Related]
47. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP. Andrews AM; Murphy DL J Neurochem; 1993 Mar; 60(3):1167-70. PubMed ID: 8094744 [TBL] [Abstract][Full Text] [Related]
48. Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse. Hallman H; Lange J; Olson L; Strömberg I; Jonsson G J Neurochem; 1985 Jan; 44(1):117-27. PubMed ID: 3880581 [TBL] [Abstract][Full Text] [Related]
49. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogues on the dopaminergic nigrostriatal pathway in mice. Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC Neurosci Lett; 1985 Jul; 58(1):133-7. PubMed ID: 3876523 [TBL] [Abstract][Full Text] [Related]
50. GM1 ganglioside protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. Janson AM; Agnati LF; Fuxe K; Cintra A; Sundstrom E; Zini I; Toffano G; Goldstein M Acta Physiol Scand; 1988 Apr; 132(4):587-8. PubMed ID: 3265839 [No Abstract] [Full Text] [Related]
51. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: relationships between monoamine oxidase, MPTP metabolism and neurotoxicity. Heikkila RE; Hess A; Duvoisin RC Life Sci; 1985 Jan; 36(3):231-6. PubMed ID: 3917525 [TBL] [Abstract][Full Text] [Related]
52. Administration of GM1 ganglioside restores the dopamine content in striatum after chronic treatment with MPTP. Hadjiconstantinou M; Rossetti ZL; Paxton RC; Neff NH Neuropharmacology; 1986 Sep; 25(9):1075-7. PubMed ID: 3490632 [TBL] [Abstract][Full Text] [Related]
53. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice. D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368 [TBL] [Abstract][Full Text] [Related]
54. Alteration of neurotensin receptors in MPTP-treated mice. Tanji H; Araki T; Fujihara K; Nagasawa H; Itoyama Y Peptides; 1999; 20(7):803-7. PubMed ID: 10477079 [TBL] [Abstract][Full Text] [Related]
55. The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurones in white and black mice. Antagonism by monoamine oxidase inhibitors. Bradbury AJ; Costall B; Jenner PG; Kelly ME; Marsden CD; Naylor RJ Neuropharmacology; 1986 Aug; 25(8):897-904. PubMed ID: 3022182 [TBL] [Abstract][Full Text] [Related]
56. MPTP toxicity in relation to age, dopamine uptake and MAO-B activity in two rodent species. Jossan SS; Sakurai E; Oreland L Pharmacol Toxicol; 1989 Mar; 64(3):314-8. PubMed ID: 2786198 [TBL] [Abstract][Full Text] [Related]
57. Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. Janson AM; Fuxe K; Sundström E; Agnati LF; Goldstein M Acta Physiol Scand; 1988 Apr; 132(4):589-91. PubMed ID: 3265840 [No Abstract] [Full Text] [Related]
58. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989 [TBL] [Abstract][Full Text] [Related]
59. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum. Chan P; Langston JW; Di Monte DA J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Youngster SK; Sonsalla PK; Heikkila RE J Neurochem; 1987 Mar; 48(3):929-34. PubMed ID: 3492590 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]